Approval · Notice of Compliance 2682 · 1998
MALARONE: Notice of Compliance 2682
Issued June 22, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2682
- Date
- June 22, 1998
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antimalarial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MALARONE | 02238151 | Marketed |
Medicinal ingredients
- ATOVAQUONE 250 MG per TAB
- PROGUANIL HYDROCHLORIDE 100 MG per TAB